Amerant Bancorp (AMTB) Q4 2025 earnings review
The 'Kitchen Sink' Quarter: Costs Explode as Asset Quality Slides
Amerant delivered a drastic strategic reset in Q4, resulting in a collapse in reported profitability. Net Income fell to $2.7M (EPS $0.07) from $14.8M in Q3, driven by a massive surge in non-interest expenses ($106.8M) related to staff separations, contract terminations, and loan write-downs. While the bank frames this as a necessary 'clean up' to position for 2026, the underlying credit metrics deteriorated significantly: Non-Performing Assets (NPAs) jumped 34% and Classified Loans surged 47%. The efficiency ratio blew out to 95%. While a new $40M buyback and maintained dividend signal confidence, the immediate picture is one of expensive restructuring and rising credit stress.
🐂 Bull Case
The $29M in non-core expenses (severance, contract kills, valuation losses) are largely one-time items. Management guides for expenses to drop drastically to ~$70-71M in 1Q26, which would immediately restore profitability if achieved.
Despite the earnings miss, the Board authorized a new $40M share repurchase program (approx. 5% of market cap) and maintained the $0.09 dividend. Trading at ~0.78x Tangible Book Value, buybacks are highly accretive.
🐻 Bear Case
The 'clean up' isn't finished. NPAs spiked to $186.9M (1.91% of assets) and Classified Loans jumped nearly 50% to $354.8M. The bank is moving loans to 'held for sale' at losses, indicating a lack of confidence in working them out.
Net Interest Margin (NIM) compressed from 3.92% to 3.78% in Q4. Guidance for 1Q26 sees further compression to 3.65-3.70%, suggesting the peak spread revenue is behind them.
⚖️ Verdict: 🔴
Bearish. While 'kitchen sink' quarters often mark a bottom, the simultaneous explosion in operating costs and deterioration in credit quality (NPAs +34%) makes this a high-risk turnaround. The bank must prove 1Q26 expenses can actually drop by $36M sequentially.
Key Themes
Credit Quality Deterioration
Asset quality metrics are flashing red. Non-performing assets (NPAs) rose to $186.9M (1.91% of assets) from $139.9M in Q3. More concerning is the pipeline of trouble: Classified loans surged 47% QoQ to $354.8M. The bank recorded $14.9M in losses on loans moved to 'held for sale,' signaling a willingness to take immediate hits to offload risk, but implying book values were inflated.
Expense Efficiency Collapse
The Efficiency Ratio hit a staggering 95.19% in Q4 (up from 69.8% in Q3). Non-interest expenses exploded to $106.8M. While $29.2M is labeled 'non-core' (restructuring, contract terminations), the sheer scale of the overrun raises questions about operational control. Even the 'Core' efficiency ratio worsened to 72.6%.
Strategic 'Clean Up' Actions
New interim leadership is aggressively clearing the decks. Q4 included $7.5M in contract termination costs (advertising, white-label loans) and $3.8M in staff separation costs. The thesis is that pain taken now secures a leaner run-rate (~$67-68M quarterly expenses) by end of 2026.
Balance Sheet Shrinkage
Total assets dipped below the psychological $10B mark to $9.8B (down 6% QoQ). This was intentional, driven by a reduction in cash equivalents and a $245M drop in gross loans. This 'shrink to health' strategy helps capital ratios (CET1 improved to 11.80%) but limits near-term revenue potential.
Core Deposit Stabilization
A silver lining: despite the turmoil, core deposits (excluding time deposits) held relatively stable at $5.8B (down slightly from $6.2B). The cost of total deposits decreased to 2.34% from 2.41% in Q3, showing the bank can lower funding costs even while shrinking.
Other KPIs
Decelerating. Down 14bps from 3.92% in Q3. The bank guides for further compression to 3.65-3.70% in 1Q26, indicating that the benefit of asset repricing is being overtaken by the shrinking balance sheet and competitive pressures.
Stable. Up slightly from $22.32 in Q3 despite the earnings hit, likely supported by the reduction in shares outstanding from buybacks (0.7M shares repurchased in Q4). The stock trades significantly below this metric.
Improving optically, but misleading. Provision dropped from $14.6M in Q3, but this is only because the bank took massive direct write-downs ($14.9M loss on sale) and charge-offs through the P&L elsewhere, rather than building the allowance.
Guidance
Reversing. A massive drop projected from the $106.8M reported in Q4. If achieved, this validates the 'one-time' nature of Q4 charges. Management expects this to trend down further to $67-68M by year-end 2026.
Decelerating. Down from 3.78% in Q4. Indicates continued pressure on spread income despite the Fed easing cycle.
Stable/Stagnant. Management projects Q1 balances at similar levels to Q4, with annualized growth of 7-9% appearing later. This confirms the 'shrink to health' phase is not quite over.
Key Questions
Confidence in Expense Cut Execution
Non-interest expenses need to drop by ~$36M sequentially to hit your Q1 guidance. Beyond the specific one-offs, what structural changes guarantee this lower run-rate immediately in Q1?
Classified Loan Migration
Classified loans spiked 47% this quarter. Are we near the peak of risk migration, or is there a specific portfolio segment (e.g., CRE Office/Syndicated) where you expect further downgrades in 1H26?
Capital Preservation vs. Returns
With NPAs rising and earnings thin, why is now the right time for a new $40M repurchase program rather than preserving capital to absorb potential further credit marks?
Valuation of Loans Held for Sale
You recorded significant losses (~15-20%) on loans moved to Held for Sale. Does this imply the remaining Held for Investment book is currently overvalued relative to market exit prices?